Myelodysplastic Syndromes (MDS)

Dr. Zhang is a board-certified hematologist. She is also an assistant professor of hematology at Stanford University School of Medicine. In addition to her medical degree, she holds a PhD in cellular and molecular immunology. In her clinical practice, she treats patients with all forms of hematological malignancies, offering specialized expertise in acute myeloid leukemia, including therapy-resistant cases. For each patient, she develops a personalized care plan encompassing novel treatment options. Her research activities include conducting early phase clinical trials, investigator initiated

Yazan Madanat, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center. Dr. Madanat earned his medical degree at the University of Jordan. He completed his residency training in internal medicine at the Cleveland Clinic and then received advanced training in hematology and medical oncology through a fellowship at the Cleveland Clinic Taussig Cancer Institute. Certified by the American Board of Internal Medicine, he joined the UT Southwestern leukemia and hematopoietic cell transplant program in the Division of Hematology and Oncology in 2019. Dr

Zahra Pakbaz MD is a board certified hematologist and associate clinical professor. in collaboration with her other team members, Dr Pakbaz provides comprehensive care for hematological disorders including bone marrow failures aplastic anemia, and MDS, Paroxysmal Nocturnal Hemoglobinuria (PNH) and other rare anemias as well as Myeloproliferative Neoplasm (polycythemia vera, essential thrombocytosis, myelofibrosis) and LGL She is passionate about delivering patient-centered care to people with blood disorders, and she works collaboratively with primary care physicians and other specialists. She